Varanakis Ann 4
4 · LifeStance Health Group, Inc. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
LifeStance (LFST) CPO Ann Varanakis Receives Award; Shares Withheld
What Happened
Ann Varanakis, Chief People Officer of LifeStance Health Group (LFST), received equity awards that vested on March 9, 2026: 86,625 shares were reported as acquired (award/vesting). To satisfy tax withholding on the net settlement, 44,963 shares were withheld at $6.91/share (total value withheld ≈ $310,694). These withholdings are reductions of the shares issued upon vesting and are not open-market sales. Net shares issued to Varanakis after withholding: 41,662.
Key Details
- Transaction date: March 9, 2026; Form 4 filed March 11, 2026 (appears timely within the two-business-day window).
- Awarded (A): 26,836 and 59,789 shares (total 86,625) — vested RSUs/PSUs from prior grants (see footnotes).
- Withheld for taxes (F): 8,707; 11,232; 25,024 shares (total 44,963) at $6.91/share, totaling ≈ $310,694.
- Net newly issued to insider after withholding: 41,662 shares (86,625 − 44,963).
- Shares owned after the transaction: not specified in the provided filing details.
- Footnotes: awards include performance-based RSUs/PSUs granted March 6, 2025 and February 27, 2025; F codes denote tax withholding via net settlement (not open-market sales).
Context
These entries reflect vested equity awards and routine corporate tax withholding (net settlement). This is not a purchase or an open-market sale by the insider. For retail investors, vested awards and tax-withholding actions are common compensation events and generally do not, by themselves, indicate the insider’s view on the company’s stock.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-03-09$6.91/sh−8,707$60,165→ 371,668 total - Award
Common Stock
[F2]2026-03-09+26,836→ 398,504 total - Tax Payment
Common Stock
[F3]2026-03-09$6.91/sh−11,232$77,613→ 387,272 total - Award
Common Stock
[F4]2026-03-09+59,789→ 447,061 total - Tax Payment
Common Stock
[F5]2026-03-09$6.91/sh−25,024$172,916→ 422,037 total
Footnotes (5)
- [F1]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
- [F2]Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026.
- [F3]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
- [F4]Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026.
- [F5]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.